Amphastar Pharmaceuticals, Inc. (AMPH) vs ANI Pharmaceuticals, Inc. (ANIP)
- Amphastar Pharmaceuticals, Inc. AMPH 25.87 −2.08%
- ANI Pharmaceuticals, Inc. ANIP 72.08 −0.28%
Amphastar Pharmaceuticals, Inc. and ANI Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. ANI Pharmaceuticals, Inc. is the larger, with a market value of $1.7B against $1.1B — 1.5× the size. Amphastar Pharmaceuticals, Inc. trades at the lower P/E: 14.9× against 14.9×. ANI Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 30.9% against 1.02%. ANI Pharmaceuticals, Inc. has the higher net margin (11.0% vs 10.8%) and the higher return on invested capital (11.3% vs 6.57%). Across the 22 metrics below, ANI Pharmaceuticals, Inc. leads on 12 and Amphastar Pharmaceuticals, Inc. on 10.
Valuation
Profitability
| Metric | AMPH | ANIP | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 47.68% | 60.40% | 53.94% |
| Operating margin | 15.66% | 15.37% | 0.00% |
| Net margin | 10.76% | 11.04% | 0.00% |
| Free cash flow margin | 20.94% | 17.12% | 0.00% |
| Return on equity | 10.30% | 20.88% | (0.40%) |
| Return on assets | 4.68% | 7.61% | (3.32%) |
| Return on invested capital | 6.57% | 11.30% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack